Full Spectrum: The Next Revolution in Extraction
Ryan Allway
August 26th, 2020
App, Exclusive, Psychedelics, Top News
The cannabis industry has rapidly matured over the past few years as legalization has swept North America and other parts of the world. While cannabis flower and distillates dominated the early market, patient and consumer preferences have shifted toward higher-quality products that provide more benefits—such as full-spectrum cannabis oils.
Let’s take a look at the difference between distillate and full-spectrum cannabis oil and how to invest in the next revolution in extraction.
What Are Distillates?
Distillate is cannabis oil that has been heavily refined and separated into cannabinoid fractions. After extracting the raw cannabis oil, cannabinoids are separated out by their molecular weight using a short path distillation system. These cannabinoids are often combined with terpenes and flavorings and sold in vape cartridges or other products.
Many cannabis oil manufacturers prefer distillates because they are predictable and relatively cheap to produce since they can be made with low-potency materials (e.g. trim). In addition, distillate oil can be easily combined with artificial flavors to mask poor taste and/or standardize a product to make it highly predictable for consumers.
The problem with distillate is that it only contains specific cannabinoids. New research has underscored the benefits of the so-called entourage effect whereby all components of the cannabis plant act together to create a high or support overall wellness. The over-expression of any single cannabinoid could have adverse impacts, such as paranoia or anxiety.
What is Full-Spectrum?
Full-spectrum cannabis oil contains a wide variety of cannabis compounds, including cannabinoids, terpenes, flavonoids and other micro- compounds. Using supercritical CO2 extraction, cannabis oil manufacturers can extract a much wider range of compounds to provide these benefits to consumers in vape cartridges or other formats.
Distillate vs. Isolate vs. Full-Spectrum Cannabis Oil – Source: Heylo Cannabis
Unlike distillate, full-spectrum cannabis oil is more difficult to produce and requires high-quality input materials, such as full bud, high-potency, terpene-rich flower since the taste more closely resembles the plant inputs. The good news is that these full-spectrum cannabis oils are premium products that can often be sold at a higher margin.
Click here to invest in a company specializing in full spectrum extraction
The term full-spectrum is not regulated by any industry body, which means that all full-spectrum products aren’t equal. In other words, full spectrum doesn’t have the same requirements as a word like ‘organic’ in the food industry. Consumers and product manufacturers must carefully vet where they acquire cannabis oil to ensure quality.
Investing in the Trend
There are several publicly traded cannabis companies, but only a handful are pure-plays in extraction. Of those companies, only a few specialize in the production of full-spectrum cannabis oil rather than producing simple distillates. Investors may want to take a closer look at these companies given the industry’s shifting focus.
Pure Extract Technologies Inc. is actively preparing to list on the Canadian Stock Exchange (CSE) under the ticker symbol ‘PULL’. With a facility designed to EU-GMP specifications and cutting-edge CO2 extraction equipment, the Company operates on the leading edge of the full-spectrum cannabis oil revolution, developing both in-house and white-label solutions for the industry.
The Company has already signed agreements with Licensed Producers to procure biomass and toll process that biomass into cannabis oil. In addition to the high-margin, recurring revenue of toll processing, the Company is developing its own in-house brands that it plans on selling into the market, providing investors with blue sky potential.
Click here to invest in a company specializing in full spectrum extraction
Looking Ahead
Cannabis extraction is maturing from simple distillates to high-quality full-spectrum cannabis oils. Investors looking to capitalize on these trends may want to take a look at Pure Extract Technologies Inc., as an upcoming pure-play on full-spectrum cannabis extraction.
In addition to cannabis, Pure Extracts has recently announced plans to move into mushroom extraction. The rise in demand for psilocybin and other functional mushroom products to address mental health disorders is rapidly creating a horizontal market that the Company could expand into with little investment and significant scale.
For more information, visit the company’s website or download their investor presentation.
Disclaimer
The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
Cansortium is a US Based, vertically integrated cannabis company with a global mission: deliver the highest standards of cannabis care from nursery to lab to shelf.
Chooze Corp. is the owner of the popular LucidMood brand of functional cannabis products positioned as “cannabis for the rest of us”. The company’s flagship product is a disposable vape pen that’s formulated by a neuroscientist using precise ratios of cannabinoids and terpenes to elevate specific moods, such as “energy”, “chill” and “party” while keeping […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
